Catalyst Pharmaceuticals Partners, Inc. Income Statement
CPRX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Catalyst Pharmaceuticals Partners, Inc. reported $589M in revenue and $214M in net income for FY2025. Revenue has grown at a 174.6% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $589.0M | $491.7M | $398.2M | $214.2M | $140.8M | $119.1M | $102.3M | $500.0K | $0 | $0 | $0 | $0 | $0 | $0 | - |
| Cost of Revenue | $87.3M | $68.8M | $52.0M | $34.4M | $21.9M | $17.0M | $14.8M | - | - | - | - | - | - | - | - |
| SG&A Expense | $193.8M | $177.7M | $133.7M | $57.1M | $49.6M | $44.2M | $36.9M | $15.9M | $8.6M | $7.9M | $8.6M | $4.5M | $2.2M | $2.6M | $2.7M |
| R&D Expense | $12.7M | $12.6M | $93.2M | $19.8M | $16.9M | $16.5M | $18.8M | $19.9M | $11.8M | $11.4M | $11.8M | $10.1M | $8.1M | $2.7M | $3.4M |
| Operating Income | $257.8M | $195.1M | $86.8M | $101.8M | $52.4M | $41.3M | $31.8M | -$35.3M | -$20.4M | -$19.3M | -$20.4M | -$14.6M | -$10.3M | -$5.2M | -$6.1M |
| Income Tax | $69.2M | $52.4M | $23.1M | $21.6M | $13.2M | -$33.1M | $1.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - |
| Net Income | $214.3M | $163.9M | $71.4M | $83.1M | $39.5M | $75.0M | $31.9M | -$34.0M | -$20.2M | -$18.1M | -$20.2M | -$15.5M | -$12.2M | -$4.1M | -$6.4M |
| EPS (Basic) | $1.75 | $1.38 | $0.67 | $0.80 | $0.38 | -$0.33 | -$0.33 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | $1.68 | $1.31 | $0.63 | $0.75 | $0.37 | -$0.33 | -$0.33 | -$0.21 | -$0.25 | -$0.22 | -$0.25 | -$0.24 | - | - | - |
| Shares Outstanding | 122.5M | 120.9M | 107.1M | 105.3M | 103.0M | 103.4M | 102.7M | 102.5M | 83.0M | 83.0M | 82.9M | 69.1M | 45.5M | 30.0M | 21.7M |
| Operating Margin | 43.8% | 39.7% | 21.8% | 47.5% | 37.2% | 34.7% | 31.1% | -7059.0% | - | - | - | - | - | - | - |
| Profit Margin | 36.4% | 33.3% | 17.9% | 38.8% | 28.0% | 63.0% | 31.2% | -6800.7% | - | - | - | - | - | - | - |